Siddharth Narayanan

Dr. Siddharth Narayanan

Nationwide Children's Hospital
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
CWColton D Wayne
Colton D Wayne
CBChahrazed Benbetka
Chahrazed Benbetka
GBGail Besner
Gail Besner
SNSiddharth Narayanan
Siddharth Narayanan
Type 3c diabetes mellitus (T3cDM), also known as pancreatogenic or pancreoprivic diabetes, is a specific type of DM that often develops as a result of diseases affecting the exocrine pancreas, exhibiting an array of hormonal and metabolic characteristics. Several pancreatic exocrine diseases and surgical procedures may cause T3cDM. Diagnosing T3cDM remains difficult as the disease characteristics frequently overlap with clinical presentations of type 1 DM (T1DM) or type 2 DM (T2DM). Managing T3cDM is likewise challenging due to numerous confounding metabolic dysfunctions, including pancreatic endocrine and exocrine insufficiencies and poor nutritional status. Treatment of pancreatic exocrine insufficiency is of paramount importance when managing patients with T3cDM. This review aims to consolidate the latest information on surgical etiologies of T3cDM, focusing on partial pancreatic resections, total pancreatectomy, pancreatic cancer and trauma.

27 November 2024 in Lipidology
Verified
Journal Article
Open access
PDF file
TJTaylor Harrison Jacobs
Taylor Harrison Jacobs
CWColton D Wayne
Colton D Wayne
NSNitin Sajankila
Nitin Sajankila
SNSiddharth Narayanan
Siddharth Narayanan
Dyslipidemia (DL), defined by dysregulated levels of lipids in the bloodstream, is an ever-growing problem in modern society. In addition to those with congenital defects in lipid metabolism, the pervasive nature of high-fat and high-calorie diets in modern industrialized societies has led to a meteoric increase in its incidence. Patients who suffer from this condition subsequently are at a higher risk of developing other co-morbid conditions, most notably diabetes mellitus and coronary artery disease. This review explores another arguably lesser-known consequence of DL, pancreatitis, which is an inflammatory disease of the pancreas. The goal of this article is to review the intersection of these two conditions by briefly highlighting the proposed pathophysiology and exploring the impact of DL (specifically hypertriglyceridemia) on acute, acute recurrent, and chronic pancreatitis. This paper additionally examines the long-term risks of developing pancreatic cancer in patients with pancreatitis secondary to DL and presents unique clinical scenarios that result in DL-associated pancreatitis. Finally, we discuss potential treatment options for hypertriglyceridemia which can potentially mitigate the risk of DL-associated pancreatitis.

20 August 2020 in The Open Neurology Journal
Verified
Journal Article
Open access
PDF file
MEMarwa Elnazeir
Marwa Elnazeir
SNSiddharth Narayanan
Siddharth Narayanan
PBPradeepthi Badugu
Pradeepthi Badugu
AHAbid Hussain
Abid Hussain
CSCody B. Stephens
Cody B. Stephens
APAdriana E. Palade
Adriana E. Palade
Neurological Manifestations Associated with Synthetic Cannabinoid Use- A Case Series

1 August 2025 in Endocrines
Verified
Journal Article
Open access
PDF file
EMEthan Mills
Ethan Mills
BDBeckey P. DeLucia
Beckey P. DeLucia
CWColton D Wayne
Colton D Wayne
TJTaylor Harrison Jacobs
Taylor Harrison Jacobs
GBGail Besner
Gail Besner
SNSiddharth Narayanan
Siddharth Narayanan
Pancreatic neuroendocrine neoplasms (PNENs) are a diverse group of rare tumor subtypes, representing less than 2% of all pancreatic tumors. Often detected late in the clinical course, they are associated with high rates of morbidity and mortality. Hereditary syndromes such as multiple endocrine neoplasia type-1 and von Hippel–Lindau are associated with the development of PNENs, although only a small portion of total tumors have a genetic basis. This review aims to explore the recent advances in laboratory diagnostics, imaging modalities, medical management, and surgical approaches to hormone-producing PNENs (including some common, less common, and some rare subtypes), with the goal of assisting physicians in the integration of evidence-based information into their practice.

22 September 2023
Verified
Book Chapter
Closed access
PDF file
SNSiddharth Narayanan
Siddharth Narayanan
KSKrishna Kumar Samaga
Krishna Kumar Samaga
AKAhad Ahmed Kodipad
Ahad Ahmed Kodipad
SMSri Prakash L. Mokshagundam
Sri Prakash L. Mokshagundam
JNJaimie D Nathan
Jaimie D Nathan
ABAppakalai N. Balamurugan
Appakalai N. Balamurugan

14 August 2025 in Emergency Care and Medicine
Verified
Journal Article
Open access
PDF file
CWColton D Wayne
Colton D Wayne
TJTaylor Harrison Jacobs
Taylor Harrison Jacobs
KAKyle J. Alexander
Kyle J. Alexander
ZDZachary Dumbauld
Zachary Dumbauld
SNSiddharth Narayanan
Siddharth Narayanan
FMForrest Moore
Forrest Moore
The ability to provide ambulatory and mobile surgery services in rural and austere environments has seen tremendous growth in recent decades due to innovations in surgical techniques and equipment. These advances have been implemented in both civilian and military settings, increasing the capabilities of surgeons and surgical subspecialists across the globe. This review aims to briefly explore the history of ambulatory and mobile surgery and describe the recent efforts to make advancements in this field to improve global surgery opportunity and access, as well as to provide an overview of both military and civilian utilizations of mobile surgical teams and strategies.